Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction

被引：49

作者：

Cerrillo, Maria ^{[1
]}

Rodriguez, Sara ^{[1
]}

Mayoral, Mercedes ^{[1
]}

Pacheco, Alberto ^{[1
]}

Martinez-Salazar, Javier ^{[1
]}

Garcia-Velasco, Juan A. ^{[1
,2
]}

机构：

[1] IVI Madrid, Madrid 28035, Spain

[2] Rey Juan Carlos Univ, Madrid, Spain

来源：

FERTILITY AND STERILITY | 2009年 / 91卷 / 04期

关键词：

OVARIAN HYPERSTIMULATION SYNDROME; ENDOTHELIAL GROWTH-FACTOR; HIGH-RISK; ANTAGONIST; PERMEABILITY; PATHOGENESIS; PROTOCOL; SERUM; RATS; IVF;

D O I：

10.1016/j.fertnstert.2008.08.118

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

In a prospective cohort study, we compared the effect of hCG and GnRH agonist triggering of final oocyte maturation on vascular endothelial growth factor production. Vascular endothelial growth factor follicular fluid concentration was significantly lower in response to GnRH agonist versus hCG, which may partially explain the absence of OHSS in these of women. (Fertil Steril (R) 2009;91:1526-8. (C)2009 by American Society for Reproductive Medicine.)

引用

收藏

页码：1526 / 1528

页数：3

相关论文

共 16 条

[1]

Abramov Y, 1997, FERTIL STERIL, V68, P133

[2] Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates [J].

Acevedo, Belen ;

Gomez-Palomares, Jose Luis ;

Ricciarelli, Elisabetta ;

Hernandez, Eleuterio R. .

FERTILITY AND STERILITY, 2006, 86 (06) :1682-1687

[3] Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol [J].

Asimakopoulos, Byron ;

Koster, F. ;

Felberbaum, R. ;

Al-Hasani, S. ;

Diedrich, K. ;

Nikolettos, Nikos .

HUMAN REPRODUCTION, 2006, 21 (12) :3091-3095

[4] Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment:: a prospective randomized trial [J].

Babayof, R ;

Margalioth, EJ ;

Huleihel, M ;

Amash, A ;

Zylber-Haran, E ;

Gal, M ;

Brooks, B ;

Mimoni, T ;

Eldar-Geva, T .

HUMAN REPRODUCTION, 2006, 21 (05) :1260-1265

[5] Peripheral arterial vasodilation hypothesis:: a new insight into the pathogenesis of ovarian hyperstimulation syndrome [J].

Balasch, J ;

Fábregues, F ;

Arroyo, V .

HUMAN REPRODUCTION, 1998, 13 (10) :2718-2730

[6] The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].

Engmann, Lawrence ;

DiLuigi, Andrea ;

Schmidt, David ;

Nulsen, John ;

Maier, Donald ;

Benadiva, Claudio .

FERTILITY AND STERILITY, 2008, 89 (01) :84-91

[7] GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS [J].

Engmann, Lawrence .

REPRODUCTIVE BIOMEDICINE ONLINE, 2006, 13 (05) :639-644

[8] Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability [J].

Gömez, R ;

Simón, C ;

Remohí, J ;

Pellicer, A .

BIOLOGY OF REPRODUCTION, 2003, 68 (06) :2164-2171

[9] Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade [J].

Gómez, R ;

Simón, C ;

Remohí, J ;

Pellicer, A .

ENDOCRINOLOGY, 2002, 143 (11) :4339-4348

[10] GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis [J].

Griesinger, G ;

Diedrich, K ;

Devroey, P ;

Kolibianakis, EM .

HUMAN REPRODUCTION UPDATE, 2006, 12 (02) :159-168